MECAMYLAMINE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for mecamylamine hydrochloride and what is the scope of freedom to operate?
Mecamylamine hydrochloride
is the generic ingredient in two branded drugs marketed by Targacept and Lgm Pharma, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for mecamylamine hydrochloride. Two suppliers are listed for this compound.
Summary for MECAMYLAMINE HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Clinical Trials: | 31 |
Patent Applications: | 740 |
What excipients (inactive ingredients) are in MECAMYLAMINE HYDROCHLORIDE? | MECAMYLAMINE HYDROCHLORIDE excipients list |
DailyMed Link: | MECAMYLAMINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for MECAMYLAMINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Vanderbilt University Medical Center | Early Phase 1 |
Wayne State University | Phase 4 |
AstraZeneca | Phase 2 |
Pharmacology for MECAMYLAMINE HYDROCHLORIDE
Drug Class | Autonomic Ganglionic Blocker |
Physiological Effect | Decreased Autonomic Ganglionic Activity |
Medical Subject Heading (MeSH) Categories for MECAMYLAMINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for MECAMYLAMINE HYDROCHLORIDE
US Patents and Regulatory Information for MECAMYLAMINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lgm Pharma | MECAMYLAMINE HYDROCHLORIDE | mecamylamine hydrochloride | TABLET;ORAL | 204054-001 | Mar 19, 2013 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Targacept | INVERSINE | mecamylamine hydrochloride | TABLET;ORAL | 010251-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.